This means your body can produce it even if it's not consumed via food
A 2006 Phase I trial of CJC-1295 reported no serious adverse events across a small number of subjects, but it was a safety study, not an outcomes trial, and there are no large trials showing it does what enthusiasts hope
2022 (atherosclerosis RCT): A clinical trial in 157 individuals aged 5875 with metabolic syndrome who received 1 g L-carnitine or placebo twice daily for 6 months found that total cholesterol and LDL cholesterol levels were higher in participants taking L-carnitine
However, like any medication, GLP-1s bring along their set of considerations, with constipation being a topic that deserves attention
Endothelial dysfunction and prognosis During the past 10 years, numerous clinical trials have demonstrated a close association between coronary and peripheral endothelial function and the likelihood of cardiovascular events
How to choose a safer provider If you decide to proceed with injections, rigorous vetting is essential